Primers Patents (Class 536/24.33)
-
Publication number: 20140053294Abstract: Primers suitable for nucleic acid sequence amplification of Pongamia plant genetic markers and a method of genetic analysis of Pongamia plants are provided. The primers comprise a repeat unit of two or three nucleotides repeated five to ten times together with a three prime extension of two or three nucleotides. Genetic markers amplified by the primers are also provided, from which may be produced further primers for genetic analysis of Pongamia plants. The primers, genetic markers and methods of genetic analysis may be suitable for selection and breeding of Pongamia plants having desired traits such as, or relating to, seed size, seed number, seed oil content, seed oil quality, seed flavour and toxicity, disease resistance, water use efficiency, nitrogen use efficiency, precocious flowering, flowering time, tree size, tree shape, growth rate, drought tolerance, salinity tolerance and/or growth in low-nutrient soils.Type: ApplicationFiled: November 18, 2011Publication date: February 20, 2014Applicant: The University of QueenslandInventor: Peter M. Gresshoff
-
Publication number: 20140051087Abstract: The present invention is directed to methods, compositions and reaction mixtures for multiplexing COLD-PCR/ice-COLD-PCR to enrich simultaneously several low abundance alleles (mutant target sequences) from a sample. The invention also involves COLD-PCR/ice-COLD-PCR amplification performed on DNA fragments that have different melting temperatures, and therefore different critical denaturation temperatures, in a graded temperature approach such that mutation enrichment is achieved on all diverse DNA fragments simultaneously (temperature-independent COLD-PCR or TI-COLD-PCR). The invention also involves methods for enabling identification of variant-sequence alleles in the presence of a large excess of non-variant alleles in nucleic acids without the complication of polymerase-introduced errors or other primer-introduced artifacts.Type: ApplicationFiled: March 30, 2012Publication date: February 20, 2014Applicant: DANA-FARBER Cancer Institute, Inc.Inventor: Gerassimos Makrigiorgos
-
Publication number: 20140051086Abstract: An amplification system that provides methods and reaction components that allow for completely isothermal amplification for detection of target nucleic acid 24; allow non-enzymatic amplification for detection of target nucleic acid 24; and can be used to identify amplicons without having to create separate individual probes for each target nucleic acid 24.Type: ApplicationFiled: March 21, 2012Publication date: February 20, 2014Applicant: OHIO STATE INNOVATION FOUNDATIONInventor: Besik Kankia
-
Publication number: 20140051082Abstract: The invention relates to the identification and selection of novel genomic regions (biomarker) and the identification and selection of novel genomic region combinations which are hypermethylated in subjects with prostate cancer compared to subjects without prostate cancer. Nucleic acids which selectively hybridize to the genomic regions and products thereof are also encompassed within the scope of the invention as are compositions and kits containing said nucleic acids and nucleic acids for use in diagnosing prostate cancer. Further encompassed by the invention is the use of nucleic acids which selectively hybridize to one of the genomic regions or products thereof to monitor disease regression in a patient and the efficacy of therapeutic regimens.Type: ApplicationFiled: April 19, 2012Publication date: February 20, 2014Inventors: Michal Schweiger, Hans Lehrach, Stefan Sörnö, Thorsten Schlomm, Holger Sültmann, Guido Suter
-
Patent number: 8652782Abstract: Disclosed are compositions and methods for isolating, detecting, amplifying, and quantitating Mycobacterium-specific nucleic acids in a sample. Also disclosed are compositions and diagnostic kits comprising Mycobacterium IS6110-specific oligonucleotide amplification primers and labeled oligonucleotide detection probes that specifically bind to the amplification products obtained therefrom. Also disclosed are compositions and methods for the isolation and characterization of nucleic acids that are specific to one or more tubercular pathogens, including Mycobacterium tuberculosis, in particular, from a wide variety of samples including those of biological, environmental, clinical and/or veterinary origin.Type: GrantFiled: April 26, 2011Date of Patent: February 18, 2014Assignee: Longhorn Vaccines & Diagnostics, LLCInventors: Gerald W. Fischer, Luke T. Daum
-
Patent number: 8652810Abstract: Methods for amplification and sequencing of at least one nucleic acid comprising the following steps: (1) forming at least one nucleic acid template comprising the nucleic acid(s) to be amplified or sequenced, wherein said nucleic acid(s) contains at the 5? end an oligonucleotide sequence Y and at the 3? end an oligonucleotide sequence Z and, in addition, the nucleic acid(s) carry at the 5? end a means for attaching the nucleic acid(s) to a solid support; (2) mixing said nucleic acid template(s) with one or more colony primers X, which can hybridize to the oligonucleotide sequence Z and carries at the 5? end a means for attaching the colony primers to a solid support, in the presence of a solid support so that the 5? ends of both the nucleic acid template and the colony primers bind to the solid support; (3) performing one or more nucleic acid amplification reactions on the bound template(s), so that nucleic acid colonies are generated and optionally, performing at least one step of sequence determination ofType: GrantFiled: August 17, 2006Date of Patent: February 18, 2014Assignee: Illumina, Inc.Inventors: Celine Adessi, Eric Kawashima, Pascal Mayer, Jean-Jacques Mermod, Gerardo Turcatti
-
Publication number: 20140045188Abstract: A method and primer for quantitative assay of microRNAs (miRNAs) and application of the same are provided. In this method, miRNAs are subjected to polyadenylation and subsequent reverse transcription with miRNA-specific S-Oligo(dT) RT primers. The miRNA is then assayed in a real-time PCR quantitative assay using a miRNA-specific forward primer, a universal reverse primer and a universal probe. The methods in the present invention have improved sensitivity, specificity, and efficiency in miRNA quantification assay, providing a simple, high-throughput, and cost-effective tool applicable for the early diagnosis and prognosis of many severe diseases such as malignancy.Type: ApplicationFiled: October 17, 2013Publication date: February 13, 2014Applicant: SHENZHEN UNIVERSITYInventors: Deming GOU, Kang KANG
-
Publication number: 20140045174Abstract: Disclosed are compositions including primers and probes, which are capable of interacting with the disclosed nucleic acids, such as the nucleic acids encoding the reverse transcriptase or protease of HIV as disclosed herein. Thus, provided is an oligonucleotide comprising any one of the nucleotide sequences set for in SEQ ID NOS:1-89, and 96-104. Also provided are the oligonucleotides consisting of the nucleotides as set forth in SEQ ID NOS:1-89, and 96-104. Each of the disclosed oligonucleotides is a probe or a primer. Also provided are mixtures of primers and probes and for use in RT-PCR and primary PCR reactions disclosed herein. Provided are methods for the specific detection of several mutations in HIV. Mutations in both the reverse transcriptase and the protease of HIV can be detected using the methods described herein.Type: ApplicationFiled: October 21, 2013Publication date: February 13, 2014Applicant: Centers for Disease Control and PreventionInventors: Jeffrey A. Johnson, Walid M. Heneine
-
Publication number: 20140045881Abstract: Pancreatic Neuroendocrine Tumors (PanNETs) are a rare but clinically important form of pancreatic neoplasia. To explore the genetic basis of PanNETs, we determined the exomic sequences of ten non-familial PanNETs and then screened the most commonly mutated genes in 58 additional PanNETs. Remarkably, the most frequently mutated genes specify proteins implicated in chromatin remodeling: 44% of the tumors had somatic inactivating mutations in MEN-1, which encodes menin, a component of a histone methyltransferase complex; and 43% had mutations in genes encoding either of the two subunits of a transcription/chromatin remodeling complex consisting of DAXX (death-domain associated protein) and ATRX (alpha thalassemia/mental retardation syndrome X-linked). Clinically, mutations in the MEN1 and DAXX/ATRX genes were associated with better prognosis.Type: ApplicationFiled: January 4, 2012Publication date: February 13, 2014Applicant: The Johns Hopkins UniversityInventors: Bert Vogelstein, Kenneth W. Kinzler, Victor Velculescu, Luis Diaz, Nikolas Papadopoulos, Yuchen Jiao, Ralph Hruban
-
Patent number: 8647823Abstract: The present invention relates to a method for the synthesis of a polynucleotide on a modified surface of a substrate, wherein the modified surface is obtained by chemically modifying with macromolecules in which a plurality of termini of the branched region are bound to the surface and a terminus of the linear region is functionalized.Type: GrantFiled: January 22, 2007Date of Patent: February 11, 2014Assignees: Postech Foundation, PoscoInventors: Joon-Won Park, Bong-Jin Hong
-
Publication number: 20140038188Abstract: The invention provides methods for isothermal amplification of RNA. The methods are particularly suitable for amplifying a plurality of RNA species in a sample. The methods employ a composite primer, a second primer and strand displacement to generate multiple copies of DNA products comprising sequences complementary to an RNA sequence of interest. In another aspect, the methods employ a single primer (which is a composite primer) and strand displacement to generate multiple copies of DNA products comprising sequences complementary to an RNA sequence of interest. In some embodiments, a transcription step is included to generate multiple copies of sense RNA of an RNA sequence of interest. The methods are useful for preparation of nucleic acid libraries and substrates for analysis of gene expression of cells in biological samples. The invention also provides compositions and kits for practicing the amplification methods, as well as methods which use the amplification products.Type: ApplicationFiled: June 19, 2013Publication date: February 6, 2014Inventor: Nurith Kurn
-
Publication number: 20140041072Abstract: The invention relates to a new resistance gene, Rpi-edn2 and functional homologues or functional fragments thereof isolated from S. x edinense. Moreover, the invention relates to the use of said resistance gene, for example the use of said resistance gene in a method to increase or confer at least partial resistance in a plant to an oomycete infection. The invention provides an isolated or recombinant nucleic acid sequence comprising a nucleic acid sequence encoding one of the amino acid sequences of FIG. 4 or a functional fragment or a functional homologue thereof.Type: ApplicationFiled: May 31, 2011Publication date: February 6, 2014Applicant: COOPERATIE AVEBE U.A.Inventors: Nicolaas Clemens Maria Henricus de Vetten, Estelle Celine Verzaux, Jacobus Hubertus Vossen, Hendrik Rietman, Vivianne Gertruda Antonia Anna Vleeshouwers, Evert Jacobsen, Richard Gerardus Franciscus Visser
-
Publication number: 20140038835Abstract: The present invention features a method for diagnosing hypertrophic cardiomyopathy by detecting one or more single nucleotide polymorphisms (SNPs) of the formin homology 2 domain containing 3 gene (FHOD3).Type: ApplicationFiled: August 12, 2011Publication date: February 6, 2014Inventors: Gordon Huggins, Martin Maron
-
Patent number: 8642264Abstract: The invention provides methods for the detection of the amount of a nucleic acid in a sample. The described methods exploit the ability to disrupt and redirect a PCR direction, and the ability to physically pair nucleic acid molecules in a sample that have a reference sequence with nucleic acid molecules in the sample that have a target sequence. The redirection of the PCR reaction enables partial amplification as a preparatory step to other techniques within the same tube. The pairing can result in the presence of unpaired target or reference sequence indicating a difference in the amount of the target sequence versus the reference sequence. The methods are broadly applicable for the determination of differences in the amount of nucleic acids in diagnostic and research applications.Type: GrantFiled: March 23, 2006Date of Patent: February 4, 2014Assignee: Zoragen Biotechnologies LLPInventor: Nora Szasz
-
Patent number: 8642266Abstract: The present invention is directed to a method for performing an RT-PCR for amplifying a target RNA comprising the steps of a) lysis of a cellular sample which is supposed to contain the target RNA with a lysis buffer comprising between 0.2 M and 1 M guanidine thiocyanate, b) diluting the sample to an extend such that guanidine thiocyanate is present in a concentration of about 30 to 50 mM, c) reverse transcribing in the presence of a mixture of first strand cDNA synthesis primers, the mixture consisting of oligo dT primers and random primers, and d) subjecting the sample to multiple cycles of a thermocycling protocol and monitoring amplification of the first strand cDNA in real time.Type: GrantFiled: October 22, 2009Date of Patent: February 4, 2014Assignee: RocheDiagnostics Operations, Inc.Inventors: Martin Bergtsson, Michael Kubista, Anders Stahlberg, Linda Stroembom
-
Publication number: 20140031246Abstract: The present invention relates to the field of biomarkers. More specifically, the present invention relates to the use of biomarkers to diagnose and monitor various diseases such as cancer.Type: ApplicationFiled: July 22, 2011Publication date: January 30, 2014Applicant: THE JOHNS HOPKINS UNIVERSITYInventors: Stephen J. Meltzer, Jee-Hoon Song, Yulan Cheng
-
Publication number: 20140030723Abstract: A test kit for selecting a therapy for a steroid resistant patient presenting inflammatory symptoms comprises primer pairs or antibodies specific for at least one marker gene or protein translated from at least one marker gene, and instructions for use. The primer pairs or antibodies enable analysis of expression level of the at least one marker gene or translated protein from the at least one marker gene.Type: ApplicationFiled: October 3, 2013Publication date: January 30, 2014Applicant: INDEX PHARMACEUTICALS ABInventors: Nikolai Kouznetsov, Lisa Charlotta Bandholtz, Alexander Gielen, Oliver Von Stein, Petra Von Stein
-
Publication number: 20140030722Abstract: Methods, reagents and kits are described for the diagnosis of a female reproductive condition such as reproductive wastage, based on the detection of an alteration in a NLRP7-encoding nucleic acid or a NLRP7 polypeptide, relative to a corresponding wild-type NLRP7-encoding nucleic acid or NLRP7 polypeptide.Type: ApplicationFiled: March 16, 2012Publication date: January 30, 2014Applicant: THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITYInventor: Rima Slim
-
Publication number: 20140030710Abstract: The present invention relates to nucleic acid amplification assays for the detection of nucleic acid sequences of Gardnerella vaginalis. The present invention provides oligonucleotides that are complementary or that anneal to nucleic acid sequences of the vly gene of GV. The present invention also provides internal amplification controls (IACs) that can be used in nucleic acid amplification reactions.Type: ApplicationFiled: October 28, 2011Publication date: January 30, 2014Applicant: Becton, Dickinson and CompanyInventor: Jason P. Stevens
-
Publication number: 20140030709Abstract: Present invention relates to the Biomarkers for detecting high altitude adaptation and hypoxia responsiveness and the method thereof. The invention specifically relates to the Gene variants SNPIDs rs479200 and rs480902 in the first intron of EGLN1 (Prolyl Hydroxylase 2) gene as biomarkers for adaptation to high altitude and predisposition for high altitude pulmonary edema and hypoxia responsiveness using a novel integrative approach of phenotyping concepts of Ayurveda with population genetics, and disease genomics. More specifically, the C allele of SNP ID rs480902 and T allele of rs479200 of EGLN1 gene is more frequent in patients of HAPE and nearly absent in native highlanders. The present invention also provides primers and methods suitable for the detection of these allelic variants for the prediction of individual's adaptability to high altitude and hypoxia and/or the genetic analysis of the EGLN1 gene in a population.Type: ApplicationFiled: October 13, 2011Publication date: January 30, 2014Applicant: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCHInventors: Bhavana Prasher, Shilpi Aggarwal, Mohammed Abdul Qadar Pasha, Mitali Mukerji
-
Patent number: 8637249Abstract: The disclosed invention is related to compositions, kits and methods comprising one or more oligomers targeting 16S rRNA target nucleic acid from Campylobacter species jejuni, coli and/or lari. Compositions include amplification oligomers, detection probe oligomers and/or target capture oligomers. Kits and methods comprise at least one of these oligomers.Type: GrantFiled: November 16, 2009Date of Patent: January 28, 2014Assignee: Gen-Probe IncorporatedInventors: Michael R. Reshatoff, Jr., Jennifer J. Bungo, Shannon K. Kaplan, James J. Hogan
-
Patent number: 8637654Abstract: This invention relates to a ribonucleic acid (RNA) based assay system for body fluid identification, and in particular to a novel, multiplex, parallel assay system based on messenger RNA expressed in human tissue, and to a method for using the same.Type: GrantFiled: September 1, 2009Date of Patent: January 28, 2014Assignee: University of Central Florida Research Foundation, Inc.Inventors: John Ballantyne, Jane Juusola
-
Patent number: 8637482Abstract: The present invention relates to methods for treating chronic kidney disease (CKD) including methods for preventing or delaying onset of CKD and methods for preventing exacerbation and progression of CKD. In particular embodiments, the invention provides methods for treating a subject at risk of developing CKD comprising administering to the subject a composition comprising a) a therapeutically effective amount of at least one oligonucleotide compound which inhibits the expression of a human target gene associated with the kidney disease; and b) a pharmaceutically acceptable excipient or carrier, or mixtures thereof, thereby reducing the risk of CKD in the subject.Type: GrantFiled: June 7, 2010Date of Patent: January 28, 2014Assignee: Quark Pharmaceuticals, Inc.Inventors: Elena Feinstein, Svetlana Adamsky, Shai Erlich, Bruce Molitoris
-
Patent number: 8637245Abstract: The present invention refers to the detection of EGFR mutations in a blood (serum/plasma) sample from a subject. The method comprises: (i) obtaining the DNA from said sample; (ii) amplifying the nucleic acid sequence corresponding to a specific region of the EGFR gene by means of PCR using a Protein-Nucleic Acid probe; 10 and (iii) detecting said mutation.Type: GrantFiled: July 20, 2007Date of Patent: January 28, 2014Assignee: Pangea Biotech, S.A.Inventors: Rafael Rosell Costa, Miguel Taron Roca
-
Patent number: 8637655Abstract: Disclosed are methods for gender determination in the intron 1 region of the amelogenin locus and a newly discovered single nucleotide polymorphism (SNP) within the X chromosome of the amelogenin locus which can cause allelic dropout. Also disclosed are kits useful in gender determination.Type: GrantFiled: August 13, 2010Date of Patent: January 28, 2014Assignee: Life Technologies CorporationInventors: Julio Mulero, Robert Green, Robert Lagace, Lori Hennessy
-
Patent number: 8637062Abstract: Implant provided with a coating, with the implant being provided with an amino-functionalized parylene coating, an oligonucleotide and/or an oligopeptide having a specific bonding affinity with CD34-positive cells.Type: GrantFiled: September 21, 2007Date of Patent: January 28, 2014Inventors: Lothar Sellin, Bock-Sun Han, Annelotte Autschbach
-
Publication number: 20140024037Abstract: A method is provided for determining the zygosity of an Rf4 gene in a corn plant. A method may include performing a first PCR assay, a second PCR assay, quantifying probes used in the first and second PCR assays, and comparing the quantified probes to determine zygosity.Type: ApplicationFiled: July 23, 2013Publication date: January 23, 2014Inventors: Ruihua REN, Peizhong ZHENG, Siva Prasad KUMPATLA
-
Publication number: 20140026262Abstract: Tools are provided which allow rapid and unequivocal identification elite event A2704-12 in biological samples.Type: ApplicationFiled: August 23, 2013Publication date: January 23, 2014Applicant: BAYER CROPSCIENCE N.V.Inventor: Marc DE BEUCKELEER
-
Publication number: 20140024099Abstract: The disclosure provides a method of identifying a subject as having B-cell non-Hodgkin lymphoma (NHL) such as testing a sample from a subject for a mutation in one or more biomarkers. Also described are methods for classifying or monitoring a subject having, or suspected of having, B-cell non-Hodgkin lymphoma comprising testing the sample for a mutation in one or more biomarkers.Type: ApplicationFiled: July 18, 2013Publication date: January 23, 2014Inventors: Ryan D. Morin, Marco A. Marra, Randy D. Gascoyne, Joseph M. Connors
-
Publication number: 20140024034Abstract: The present disclosure is directed to compositions and methods for detecting signs of telomere dysfunction as diagnostic indicators of metastatic disease. More particularly, diagnostic reagents and procedures are provided for analyzing samples to detect the presence of telomere fusions as an early diagnostic test for cancerous or pre-cancerous cells.Type: ApplicationFiled: July 3, 2013Publication date: January 23, 2014Inventor: Hiromi Tanaka
-
Patent number: 8632969Abstract: A method and a device for detecting nucleic acid are disclosed, wherein impurities in a sample can be easily removed. The method comprises injecting a sample containing an adsorption medium with nucleic adsorbed thereon into a chamber; washing the sample; heating the sample to denature the nucleic acid; cooling down; and detecting nucleic acid by using the biomolecule detection device. The device includes: a source and a drain region; a gate electrode layer; a chamber formed over the semiconductor substrate including the gate electrode layer; and a heating means, wherein a gate adsorption layer to which a nucleic acid is adsorbed is formed on the gate electrode layer. A single-stranded nucleic acid is adsorbed to the gate adsorption layer, and a channel is formed between the source and the drain region. The current in the channel provides a basis to detect a gene.Type: GrantFiled: June 18, 2008Date of Patent: January 21, 2014Assignee: Samsung Electronics Co., Ltd.Inventors: Jeo Young Shim, Jung Im Han, Won Seok Chung
-
Patent number: 8632999Abstract: The present invention relates to assays and kits for carrying out said assays for the rapid, automated detection of infectious pathogenic agents and normal and abnormal genes. The present invention further relates to methods for general amplification of total mRNAs and for analyzing differential mRNA expression using the amplification methods disclosed herein.Type: GrantFiled: June 13, 2003Date of Patent: January 21, 2014Inventor: David Y. Zhang
-
Publication number: 20140017682Abstract: Compositions and methods for determining an increased likelihood of a response to a targeted treatment of a cancer disease including isolating genomic DNA from a patient sample, amplifying a fragment of DNA by means of PCR with a specific pair of amplification primers, determining if the amplified fragment comprises a wildtype sequence or a mutation by means of a High Resolution Melting Analysis (HRM), and correlating the presence or absence of a mutation with an increased likelihood of success of said targeted treatment. Respective primer pairs, compositions and kits are also claimed.Type: ApplicationFiled: June 28, 2013Publication date: January 16, 2014Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.Inventors: Reinhard Buettner, Stefanie Froehner, Sabine Merkelbach-Bruse, Jasmin Ney, Angelika Roesler
-
Publication number: 20140017686Abstract: The present invention aims at providing a method for assessing risk of hepatocellular carcinoma with high sensitivity and specificity. Extracted were 30 regions containing 45 CpG sites which have DNA methylation levels significantly different between in normal liver tissue samples and in noncancerous liver tissue samples from patients with hepatocellular carcinoma. It was found that the noncancerous liver tissue samples from patients with HCC were able to be assessed for risk of hepatocellular carcinoma by setting cutoff values for distinguishing between the normal liver tissue samples and the noncancerous liver tissue samples from patients with HCC for the extracted 30 regions.Type: ApplicationFiled: January 27, 2012Publication date: January 16, 2014Applicant: NATIONAL CANCER CENTERInventors: Yae Kanai, Eri Arai, Ryo Nagashio
-
Publication number: 20140017774Abstract: The present invention relates, in general, to a prostate-specific antigen, PCA3. In particular, the present invention relates to nucleic acid molecules coding for the PCA3 protein; purified PCA3 proteins and polypeptides; recombinant nucleic acid molecules; cells containing the recombinant nucleic acid molecules; antibodies having binding affinity specifically to PCA3 proteins and polypeptides; hybridomas containing the antibodies; nucleic acid probes for the detection of nucleic acids encoding PCA3 proteins; a method of detecting nucleic acids encoding PCA3 proteins or polypeptides in a sample; kits containing nucleic acid probes or antibodies; bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess, or prognose a mammal afflicted with prostate cancer; therapeutic uses; and methods of preventing prostate cancer in an animal.Type: ApplicationFiled: September 23, 2013Publication date: January 16, 2014Applicants: The Johns Hopkins University, Stichting Katholieke Universiteit, more particularly The Univ. Medical Centre NijmegenInventors: Marion J.G. Bussemakers, William B. Isaacs
-
Patent number: 8628916Abstract: A method for isolating Hepatitis A virus or Spring viremia of Carp virus. A virus probe is prepared by linking a magnetic bead-conjugated Protein G with an anti-HAV (Hepatitis A Virus) antibody or an anti-rhabdovirus antibody. The virus probe is contacted with a sample to be analyzed to form a virus probe-virus complex. The virus probe-virus complex is then isolated. It may specifically isolate Hepatitis A virus or Spring viremia of Carp virus from a sample mixed viruses.Type: GrantFiled: October 12, 2012Date of Patent: January 14, 2014Assignee: Industry Foundation of Chonnam National UniversityInventors: Du Woon Kim, Hee Min Lee, Se Young Cho, Sang Mu Ko, Kyung Seo Oh, Joseph Kwon, Jong Soon Choi
-
Publication number: 20140011863Abstract: The present invention provides methods for the assessment of risk of developing chronic obstructive pulmonary disease (COPD), emphysema or both COPD and emphysema in smokers and non-smokers using analysis of genetic polymorphisms.Type: ApplicationFiled: September 13, 2013Publication date: January 9, 2014Applicant: SYNERGENZ BIOSCIENCE LTDInventor: Robert Peter Young
-
Patent number: 8624015Abstract: Provided is a probe set that is useful for identifying each allele of HLA individually, and a method of identification of an allele of HLA by the use thereof for each type. The probe set is composed of probes that cover all of the partial sequences that contain a unique base to each allele. Using this probe set HLA contained in a specimen is identified.Type: GrantFiled: May 9, 2012Date of Patent: January 7, 2014Assignee: Canon Kabushiki KaishaInventor: Mamoru Tsukada
-
Patent number: 8623643Abstract: Compounds, compositions and methods are provided for inhibiting the expression of human STAT3. The compositions comprise antisense oligonucleotides targeted to nucleic acids encoding STAT3. Methods of using these oligonucleotides for inhibition of STAT3 expression and for promotion of apoptosis are provided. Methods for treatment of diseases, particularly inflammatory diseases and cancers, associated with overexpression or constitutive activation of STAT3 or insufficient apoptosis are also provided.Type: GrantFiled: April 19, 2012Date of Patent: January 7, 2014Assignee: Isis Pharmaceuticals, Inc.Inventor: James G. Karras
-
Publication number: 20140005061Abstract: The present disclosure describes compositions, methods and kits for detection of one or multiple microorganism contaminants in samples. Some embodiments relate to detecting one or more microorganisms producing virulence factors such as shiga toxin stx1 and stx2 and eae. Some embodiments relate to detection of STEC microorganisms including an E. coli O26, an E. coli O45, an E. coli O103, an E. coli O111, an E. coli O121 or an E. coli O145. In some embodiments, compositions, methods and kits can detect and identify individual serotypes of shiga toxin producing microorganisms. Workflows for multiple microbe detection and identification are also described.Type: ApplicationFiled: March 8, 2013Publication date: January 2, 2014Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Robert TEBBS, Craig Cummings, Pius Brzoska, Sharon Matheny, Catherine O'Connell, Manohar Furtado, Nikolay Sergeev, Maxim Brevnov
-
Publication number: 20140007267Abstract: The present invention provides a transgenic soybean comprising event MON87712 that exhibits increased yield. The invention also provides cells, plant parts, seeds, plants, commodity products related to the event, and DNA molecules that are unique to the event and were created by the insertion of transgenic DNA into the genome of a soybean plant. The invention further provides methods for detecting the presence of said soybean event nucleotide sequences in a sample, probes and primers for use in detecting nucleotide sequences that are diagnostic for the presence of said soybean event.Type: ApplicationFiled: October 11, 2011Publication date: January 2, 2014Applicant: Monsanto Technology LLCInventors: Robert H. Cole, John A. Korte, John R. LeDeaux, Melissa Compton Spears, Kunsheng Wu
-
Publication number: 20140007305Abstract: Two genes, A622 and NBB1, can be influenced to achieve a decrease of nicotinic alkaloid levels in plants. In particular, suppression of one or both of A622 and NBB1 may be used to decrease nicotine in tobacco plants.Type: ApplicationFiled: April 8, 2011Publication date: January 2, 2014Inventors: Takashi HASHIMOTO, Akira Kato
-
Publication number: 20140004502Abstract: Nucleic acid amplification primers and methods for specific detection of influenza A and influenza B nucleic acid targets are disclosed. The primer-target binding sequences are useful for detection of influenza A and influenza B targets in a variety of amplification and hybridization reactions. The oligonucleotide sequences are able to differentiate between influenza A and influenza B strains through specific hybridization to one or the other virus strain, enabling specific detection of the presence of influenza A and/or influenza B in a specimen.Type: ApplicationFiled: June 13, 2013Publication date: January 2, 2014Inventors: Tobin Hellyer, James A. Price, JR., Erika L. Jones
-
Publication number: 20140004504Abstract: Provided herein are compositions and methods for the detection and analysis of African swine fever virus (ASFV). In particular, kits, compositions, and methods employing LATE-PCR reagents and processes for the detection and analysis of ASFV are provided.Type: ApplicationFiled: December 9, 2011Publication date: January 2, 2014Applicant: BRANDEIS UNIVERSITYInventors: Lawrence J. Wangh, Bonnie Ronish
-
Publication number: 20140004524Abstract: The present invention relates to a marker which can be used to diagnose a diabetic retinopathy patient and determine the progression of diabetic retinopathy, a composition for diagnosing diabetic retinopathy, which comprises an agent for measuring the level of a gene or protein associated with the marker, and the use thereof.Type: ApplicationFiled: June 18, 2013Publication date: January 2, 2014Inventors: Yunhee KU, Yongju YANG, Youngsoo KIM, Jonghwa JIN, Kyunggon KIM, Moosub KIM, Seungyeon SONG
-
Patent number: 8617850Abstract: There is provided an oligonucleotide sequence capable of binding to a portion of a CAstV genome, wherein the oligonucleotide sequence has binding specificity to the precapsid region of CAstV or to cDNA of the precapsid region. The oligonucleotide sequence can be one of a primer pair for use in a method for detecting the presence of CAstV in a biological sample by reverse transcription followed by amplification of the reverse transcription products using such primer pair, or a method for amplifying CAstV cDNA using such primer pair.Type: GrantFiled: July 23, 2010Date of Patent: December 31, 2013Assignee: Agri-Food Biosciences InstituteInventors: Daniel Todd, Victoria Jane Smyth
-
Patent number: 8617811Abstract: The present invention is directed to methods and compositions for acquiring nucleotide sequence information of target sequences. In particular, the present invention provides methods and compositions for improving the efficiency of sequencing reactions by using fewer labels to distinguish between nucleotides and by detecting nucleotides at multiple detection positions in a target sequence.Type: GrantFiled: January 28, 2009Date of Patent: December 31, 2013Assignee: Complete Genomics, Inc.Inventor: Radoje Drmanac
-
Patent number: 8617816Abstract: In one embodiment of the invention a method for detecting low frequency occurrence of one or more HIV sequence variants associated with drug resistance is describe that comprises generating cDNA species from RNA molecules in an HIV sample population; amplifying first amplicons from the cDNA species, wherein each amplicon comprises amplified copies and is amplified with a pair of nucleic acid primers that define a locus; clonally amplifying the amplified copies of the first amplicons to produce second amplicons that comprise an immobilized population of substantially identical copies from one of the amplified copies of first amplicons; determining a nucleic acid sequence composition from at least 100 of the immobilized populations in parallel on a single instrument; detecting one or more sequence variants that occur at a frequency of 5% or less in the nucleic acid sequence composition of the at least 100 immobilized populations; and correlating the detected sequence variants with variation associated with HIVType: GrantFiled: March 14, 2008Date of Patent: December 31, 2013Assignee: 454 Life Sciences, A Roche CompanyInventors: Birgitte Binderup Simen, Christine Lubeski, Jan Fredrik Simons
-
Patent number: 8618071Abstract: Provided herein is a method for detection of migratory and invasive cancer cells based on a number of marker nucleic acids differentially expressed in migratory/invasive cancer cells relative to nonmigratory/noninvasive cancer cells. Also disclosed are antisense oligonucleotides of the marker nucleic acids and uses thereof for suppressing cancer cell migration and invasion.Type: GrantFiled: May 20, 2011Date of Patent: December 31, 2013Assignee: Industrial Technology Research InstituteInventors: Yen-Ju Lin, Cheng-Tao Wu, Chung-Cheng Liu
-
Patent number: RE44760Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of apolipoprotein B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding apolipoprotein B. Methods of using these compounds for modulation of apolipoprotein B expression and for treatment of diseases associated with expression of apolipoprotein B are provided.Type: GrantFiled: September 27, 2012Date of Patent: February 11, 2014Assignee: Genzyme CorporationInventors: Rosanne M. Crooke, Mark J. Graham, Susan M. Freier